Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05784688 |
Title | Study of TU2218 in Combination With Pembrolizumab in Patients With Advanced Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | TiumBio Co., Ltd |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
NEXT Oncology | RECRUITING | San Antonio | Texas | 78229-3307 | United States | Details |
Hope Cancer Center | RECRUITING | Tyler | Texas | 75701 | United States | Details |
Medical Oncology | RECRUITING | Spokane | Washington | 99208 | United States | Details |